As of January 27, 2025, enVVeno Medical Corporation (NVNO) has a market cap of $57.869 million USD. According to our data, enVVeno Medical Corporation is ranked No.8062 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 27, 2025 | $57.87 M |
9.27%
|
Dec 31, 2024 | $52.96 M |
-41.25%
|
Dec 29, 2023 | $90.14 M |
0.78%
|
Dec 30, 2022 | $89.43 M |
-22.61%
|
Dec 31, 2021 | $0.12 B |
-23.82%
|
Dec 31, 2020 | $0.15 B |
-37.09%
|
Dec 31, 2019 | $0.24 B |
-62.71%
|
Dec 31, 2018 | $0.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Medtronic
MDT
|
$118.11 B |
0.003 M
|
Ireland
|
Boston Scientific
BSX
|
$149.99 B |
-0.006 M
|
USA
|
Abbott Laboratories
ABT
|
$223.94 B |
-0.001 M
|
USA
|
Edwards Lifesciences
EW
|
$40.67 B |
-0.024 B
|
USA
|
Teleflex
TFX
|
$8.48 B |
76.168 M
|
USA
|
Becton Dickinson
BDX
|
$71.78 B |
-0.002 M
|
USA
|
Stryker Corporation
SYK
|
$151.59 B |
-0.005 M
|
USA
|
Zimmer Biomet
ZBH
|
$22.05 B |
-9.954 M
|
USA
|
Johnson & Johnson
JNJ
|
$368.65 B |
0.001 M
|
USA
|
Getinge
GETI-B.ST
|
$4.96 B |
0.368 B
|
Sweden
|
Cardinal Health
CAH
|
$31.27 B |
87.123 M
|
USA
|
AngioDynamics
ANGO
|
$0.51 B |
0.000 M
|
USA
|
Market Cap | = | NVNO Stock Price | * | NVNO Shares Outstanding |
= | $3.30 | * | 17.54 M | |
= | $57.87 M |